Viewing Study NCT00317720


Ignite Creation Date: 2025-12-25 @ 4:20 AM
Ignite Modification Date: 2025-12-26 @ 3:21 AM
Study NCT ID: NCT00317720
Status: COMPLETED
Last Update Posted: 2025-04-30
First Post: 2006-04-21
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
Sponsor: M.D. Anderson Cancer Center
Organization: